TAYLOR MOORE: Open Payments
NPI 1720768534 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 58 payments from 12 companies in 2025. Trend: 2023 $2,678 · 2024 $2,653 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $255 |
| PFIZER INC. | 12 | $195 |
| E.R. Squibb & Sons, L.L.C. | 4 | $168 |
| Novartis Pharmaceuticals Corporation | 7 | $168 |
| GlaxoSmithKline, LLC. | 4 | $167 |
| Amgen Inc. | 9 | $143 |
| Alnylam Pharmaceuticals Inc. | 4 | $90 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $21 |
Products named: VERQUVO, CAMZYOS, LEQVIO, VYNDAQEL, Repatha, AREXVY, AMVUTTRA, ONPATTRO.
Industry payments across TX — which companies pay providers there.
